FDA’s “Belt and Suspenders” Approach to Mifepristone Approval
Political pressure and wary regulators shaped FDA’s mifepristone approval in 2000.
Supreme Court Reinstates Barriers to Abortion by Telemedicine
The Court requires in-person visits for patients seeking medication abortion despite the risks of COVID-19.
Abortion Regulation in the Age of COVID-19
Both abortion advocates and opponents have used the COVID-19 crisis to further their policy goals.